Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study

[1]  Michael W. Weiner,et al.  Widespread white matter degeneration preceding the onset of dementia , 2015, Alzheimer's & Dementia.

[2]  Y. Smith,et al.  Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease , 2014, Neurobiology of Disease.

[3]  Derek K. Jones,et al.  CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment , 2014, NeuroImage.

[4]  Sylvain Bouix,et al.  Microstructural white matter alterations in acutely concussed ice hockey players : a longitudinal free-water MRI study , 2022 .

[5]  Janey Prodoehl,et al.  Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor , 2013, Movement disorders : official journal of the Movement Disorder Society.

[6]  Dorothee P. Auer,et al.  Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis☆ , 2013, NeuroImage: Clinical.

[7]  Michael Schocke,et al.  Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease. , 2013, Brain : a journal of neurology.

[8]  D. Vaillancourt,et al.  The Evolving Role of Diffusion Magnetic Resonance Imaging in Movement Disorders , 2013, Current Neurology and Neuroscience Reports.

[9]  C. Adler,et al.  Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. , 2013, Brain : a journal of neurology.

[10]  H. Matsuda,et al.  In vivo evaluation of gray and white matter volume loss in the parkinsonian variant of multiple system atrophy using SPM8 plus DARTEL for VBM☆ , 2013, NeuroImage: Clinical.

[11]  Carl-Fredrik Westin,et al.  Excessive Extracellular Volume Reveals a Neurodegenerative Pattern in Schizophrenia Onset , 2012, The Journal of Neuroscience.

[12]  Martin Styner,et al.  Imaging nigral pathology and clinical progression in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[13]  Ajay S. Kurani,et al.  Differences in brain activation between tremor- and nontremor-dominant Parkinson disease. , 2012, JAMA neurology.

[14]  G Tedeschi,et al.  Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait , 2012, American Journal of Neuroradiology.

[15]  Peter Teismann,et al.  Chelators in the Treatment of Iron Accumulation in Parkinson's Disease , 2012, International journal of cell biology.

[16]  Stéphane Lehéricy,et al.  Magnetic resonance imaging of the substantia nigra in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[17]  I. Samudio,et al.  Cellular and molecular mechanisms of antioxidants in Parkinson's disease , 2012, Nutritional neuroscience.

[18]  A. Mahadevan,et al.  Increased Oxidative Damage and Decreased Antioxidant Function in Aging Human Substantia Nigra Compared to Striatum: Implications for Parkinson’s Disease , 2012, Neurochemical Research.

[19]  Janey Prodoehl,et al.  Effects of aging on the ventral and dorsal substantia nigra using diffusion tensor imaging , 2012, Neurobiology of Aging.

[20]  Derek K. Jones,et al.  How and how not to correct for CSF-contamination in diffusion MRI , 2012, NeuroImage.

[21]  Wang Zhan,et al.  Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging , 2012, Movement disorders : official journal of the Movement Disorder Society.

[22]  K. Trinkaus,et al.  Quantification of increased cellularity during inflammatory demyelination. , 2011, Brain : a journal of neurology.

[23]  Martin Styner,et al.  Combined R2* and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[24]  A. A. Farooqui,et al.  Lipid-Mediated Oxidative Stress and Inflammation in the Pathogenesis of Parkinson's Disease , 2011, Parkinson's disease.

[25]  C. Scherfler,et al.  Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease , 2011, Journal of Neurology.

[26]  D. Louis Collins,et al.  Unbiased average age-appropriate atlases for pediatric studies , 2011, NeuroImage.

[27]  A. Stefani,et al.  Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. , 2010, Brain : a journal of neurology.

[28]  N. Intrator,et al.  Free water elimination and mapping from diffusion MRI , 2009, Magnetic resonance in medicine.

[29]  Paul M. Matthews,et al.  MRI characteristics of the substantia nigra in Parkinson's disease: A combined quantitative T1 and DTI study , 2009, NeuroImage.

[30]  M. B. Spraker,et al.  High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease , 2009, Neurology.

[31]  Paolo Zamboni,et al.  Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options , 2009, Current neuropharmacology.

[32]  S Fook-Chong,et al.  Case control study of diffusion tensor imaging in Parkinson’s disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[33]  A. Lozano,et al.  THE DOPAMINERGIC NIGROSTRIATAL SYSTEMAND PARKINSON'S DISEASE: MOLECULAR EVENTSIN DEVELOPMENT, DISEASE, AND CELL DEATH, AND NEW THERAPEUTIC STRATEGIES , 2007, Neurosurgery.

[34]  Nick C. Fox,et al.  Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease , 2004, NeuroImage.

[35]  K. Unsicker.  The dopaminergic nigrostriatal system , 2004, Cell and Tissue Research.

[36]  E. Hirsch,et al.  Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure , 2004, Glia.

[37]  Timothy Edward John Behrens,et al.  Characterization and propagation of uncertainty in diffusion‐weighted MR imaging , 2003, Magnetic resonance in medicine.

[38]  A. Pfefferbaum,et al.  Increased brain white matter diffusivity in normal adult aging: Relationship to anisotropy and partial voluming , 2003, Magnetic resonance in medicine.

[39]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[40]  A J Lees,et al.  What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study , 2001, Neurology.

[41]  D. Parker,et al.  Analysis of partial volume effects in diffusion‐tensor MRI , 2001, Magnetic resonance in medicine.

[42]  P J Slomka,et al.  Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  A. Graybiel,et al.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.

[44]  J. Rinne,et al.  A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease , 1996, Journal of the Neurological Sciences.

[45]  T. Nagatsu,et al.  Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease , 1996, Neuroscience Letters.

[46]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. 1996. , 1996, Journal of magnetic resonance.

[47]  P. Riederer,et al.  Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients , 1994, Neuroscience Letters.

[48]  Minoru Harada,et al.  Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients , 1994, Neuroscience Letters.

[49]  A. Lees,et al.  What features improve the accuracy of clinical diagnosis in Parkinson's disease , 1992, Neurology.

[50]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[51]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.

[52]  A. Graybiel,et al.  The nigrostriatal system in Parkinson's disease. , 1990, Advances in neurology.